Biolinq develops wearable glucose-sensing technology, combining glucose, activity, and sleep information with a color-changing indicator.

CandidPro combines doctor-directed clear aligner treatment with clinical support and at-home progress monitoring.

Care Delivery focuses on companies changing how care is accessed, delivered, and paid for.

Healthcare Infrastructure covers clinical trials, data, workflows, and supply chains for treatments and care models.

Conversations from Averin Capital with leaders in science, technology, and healthcare about building companies that advance human health.

Articles, analysis, and conversations from Averin Capital on AI, breakthrough technologies, human health, and building companies.

Bedford Bridge rebranded as Averin, focusing on health innovation through building, investing, and operating.

Coverage, interviews, and announcements from Averin Capital and its team on technology, human health, and company building.

Averin welcomed Mikael Dolsten to its advisory board in June 2026.

Averin Capital offers career opportunities in technology, science, and healthcare across its portfolio companies.

Help build a company from the ground up. The Averin Fellowship embeds MD/MBA, MBA, and PhD students in company creation at Averin Capital.

Averin provides career opportunities across its companies.

David Berry, MD PhD, is Managing Partner and Co-Founder of Averin Capital, bringing medical, scientific, investing, and company-building experience.

Eric Berry is Managing Partner and Co-Founder of Averin Capital and co-founder of TripleLift, bringing technology and company-building experience.

Averin Capital invests in companies transforming human health through its team of investors, founders, physicians, scientists, and operators.

Tristan Hunt, MD, is a Partner at Averin Capital, bringing physician and operating experience across longevity, virtual care, and medical devices.

Foundational Science translates advances in biology, quantum computing, materials science, and space research into research tools.

Averin Capital combines domain expertise and operating experience to back founders transforming human health through AI and breakthrough technologies.

Averin Capital invests in physical intelligence, which enables devices to sense, decide, and act.

Averin Capital connects with companies, investors, job seekers, and media.

Averin Capital discusses investment relationships with potential partners.

Averin Capital seeks companies transforming health.

Averin Capital backs and builds early-stage companies transforming human health through AI and breakthrough technologies.

Averin Capital’s privacy notice explains how personal information is handled on its website.

The Averin Capital website provides regulatory information and investment disclosures.

The Averin Capital website includes terms and conditions for use.